Problems and Perspectives in Diagnosis and Prevention of Ovarian Tumor Diseases

Petr G. Prokopenko; Valentina Poltoranina; Kirill I. Zhordania; Olga Petrenko; Innokenty M. Mokhosoev; Alexander A. Terentiev

doi:10.9734/BJMMR/2011/344

Research Article Open access CC BY 3.0

Problems and Perspectives in Diagnosis and Prevention of Ovarian Tumor Diseases

Petr G. Prokopenko, Valentina Poltoranina, Kirill I. Zhordania, Olga Petrenko, Innokenty M. Mokhosoev, Alexander A. Terentiev

Journal of Advances in Medicine and Medical Research · pp. 182–197 · Published 29 May 2011

10.9734/BJMMR/2011/344

Abstract

A set of embryonic proteins - potential markers for ovarian tumors is presented. More than ten new embryonic proteins have been tested, but no one strictly specific protein marker for diagnosis of ovarian tumors has been revealed. SOVA-1 is the most perspective marker for today. The special attention is given to peculiarities of evolution and mechanisms of early distribution of the tumor process. The role of pregnancy and “pregnancy specific glycoprotein”- PSG as a way of the ovary tumor disease prevention is discussed. An attempt to realize sources and logic of the disease is undertaken in the present work.

Ovarian tumor - peculiarities of evolution and progress embryonic proteins- perspectives of immunodiagnostics pregnancy specific glycoprotein (PSG) pregnancy as prevention measure in case of ovarian tumor disease

Cited by 1

Recombinant N-Domain of Pregnancy-Specific Glycoprotein from E. coli Cells: Analysis of the Spectrum of Polyclonal Antibodies

P. G. Prokopenko, A. N. Shkoporov, O. Yu. Petrenko · Bulletin of Experimental Biology and Medicine · 2015

Access this article

View at publisher

Cite this article

Petr G. Prokopenko, Valentina Poltoranina, Kirill I. Zhordania, Olga Petrenko, Innokenty M. Mokhosoev, Alexander A. Terentiev (2011). Problems and Perspectives in Diagnosis and Prevention of Ovarian Tumor Diseases. Journal of Advances in Medicine and Medical Research , 182–197. https://doi.org/10.9734/BJMMR/2011/344

Affiliations

Petr G. Prokopenko — Department of Biological Chemistry, N. I. Pirogov Russian State Medical University, Ostrovityanov St. 1, Moscow 117997, Russia.
Valentina Poltoranina — N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe Schosse 24, Moscow 115478, Russia.
Kirill I. Zhordania — N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe Schosse 24, Moscow 115478, Russia.
Olga Petrenko — N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe Schosse 24, Moscow 115478, Russia.
Innokenty M. Mokhosoev — N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe Schosse 24, Moscow 115478, Russia.
Alexander A. Terentiev — Department of Biological Chemistry, N. I. Pirogov Russian State Medical University, Ostrovityanov St. 1, Moscow 117997, Russia.

Metrics

0
Views: 0
Downloads: 1
Citations: 0
Outbound

Full metrics

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.